Overview

Reducing Port Access Pain and Clinic Wait Time: An Evaluation of EMLA Cream Versus nüm™ Vapocoolant Spray

Status:
Enrolling by invitation

Trial end date:
2024-08-01

Target enrollment:

Participant gender:

Summary

The goal of this clinical trial is to compare a sterile vapocoolant spray to EMLA cream in children with access ports. Participants will receive either the spray or cream prior to port access and rate pain on a scale. Researchers will compare spray vs cream to see if the spray is as effective as the cream in reducing pain associated with port puncture.

Phase:

Phase 4

Details

Lead Sponsor:

Marianne Hutti

Collaborator:

Bimeco Group

Treatments:

Lidocaine, Prilocaine Drug Combination